Epstein-Barr virus (EBV) and its associated human cancers--genetics, epigenetics, pathobiology and novel therapeutics
- PMID: 16720343
- DOI: 10.2741/2000
Epstein-Barr virus (EBV) and its associated human cancers--genetics, epigenetics, pathobiology and novel therapeutics
Abstract
Epstein-Barr virus (EBV) is a B-lymphotropic virus that is associated with a range of human malignancies. Although for many of these tumors the association has long been established, unraveling the precise role of EBV in disease pathogenesis has been more difficult. This review summarizes current knowledge concerning the association between EBV and human cancers, and illustrates how a deeper insight into viral latent gene expression, regulation and functions in different cell environments is already helping towards a better understanding of both the natural history of infection in normal individuals and how EBV contributes to malignant transformation. Finally, therapeutic strategies targeting EBV in tumors are discussed.
Similar articles
-
The Role of the Epstein-Barr virus in human disease.Front Biosci. 2002 Feb 1;7:d519-40. doi: 10.2741/murray. Front Biosci. 2002. PMID: 11815292 Review.
-
Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.J Pathol. 2015 Jan;235(2):334-41. doi: 10.1002/path.4431. J Pathol. 2015. PMID: 25186125 Review.
-
Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis.Int J Biol Sci. 2016 Oct 18;12(11):1309-1318. doi: 10.7150/ijbs.16564. eCollection 2016. Int J Biol Sci. 2016. PMID: 27877083 Free PMC article. Review.
-
Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia.Semin Cancer Biol. 2009 Jun;19(3):158-64. doi: 10.1016/j.semcancer.2009.02.012. Epub 2009 Feb 24. Semin Cancer Biol. 2009. PMID: 19429479 Review.
-
[Mechanisms of Epstein-Barr Virus-Mediated Oncogenesis].Gan To Kagaku Ryoho. 2015 Oct;42(10):1133-6. Gan To Kagaku Ryoho. 2015. PMID: 26489540 Review. Japanese.
Cited by
-
Virus-specific T cells for malignancies - then, now and where to?Curr Stem Cell Rep. 2020 Jun;6(2):17-29. doi: 10.1007/s40778-020-00170-6. Epub 2020 May 7. Curr Stem Cell Rep. 2020. PMID: 33738181 Free PMC article.
-
Clinical values of multiple Epstein-Barr virus (EBV) serological biomarkers detected by xMAP technology.J Transl Med. 2009 Aug 23;7:73. doi: 10.1186/1479-5876-7-73. J Transl Med. 2009. PMID: 19698162 Free PMC article.
-
A naturally occurring variant in human TLR9, P99L, is associated with loss of CpG oligonucleotide responsiveness.J Biol Chem. 2010 Nov 19;285(47):36486-94. doi: 10.1074/jbc.M110.117200. Epub 2010 Sep 14. J Biol Chem. 2010. PMID: 20843814 Free PMC article.
-
Case report: a diagnostically challenging conjunctival mass caused by the Epstein-Barr virus.BMC Ophthalmol. 2015 Oct 7;15:129. doi: 10.1186/s12886-015-0111-2. BMC Ophthalmol. 2015. PMID: 26447043 Free PMC article.
-
The interplay between Epstein-Bar virus (EBV) with the p53 and its homologs during EBV associated malignancies.Heliyon. 2019 Nov 14;5(11):e02624. doi: 10.1016/j.heliyon.2019.e02624. eCollection 2019 Nov. Heliyon. 2019. PMID: 31840114 Free PMC article. Review.